Sunday, November 05, 2006

Genzyme Reports Strong Third-Quarter Financial Results

Sales of Sepra(TM) products increased substantially again in the third quarter, rising 24 percent to $21.1 million from $17.0 million in the third quarter a year ago. Seprafilm(R) adhesion barrier continues to be a dynamic product, and its growing use in gynecologic surgery is helping drive overall sales.
Click here for full report

No comments: